Sir,
I was happy till recently about many progressive activities of our profession through out the country. For example, experiments done to develop community based psychiatric services; brain storming sessions conducted to strengthen the undergraduate psychiatric education. But today, I sit downcast, sharing the profession's collective guilt and responsibility for the recent fate suffered by the undergraduate psychiatric education. In its 1997 review, the Medical Council of India has reduced the medical intern's posting in psychiatry to the status of just one of the three optional postings of 10 days each out of six disciplines. The intern can choose his three disciplines for posting such that he will miss psychiatry altogether! This is an intolerable 'insult' added on to an already existing 'injury' that was being passively endured. The 'injury' is the fact that the undergraduate students are deprived of an orientation to behavioural sciences, and their clinical posting to psychiatry is restricted to 2-3 hours per day for about 20 days ! Somewhere along the line, we have failed miserably in this very important area of psychiatric education to the medical undergraduates. Our enthusiasm and rhetoric so glaringly evident in conferences, seminars and workshops has not till now matured into a collective, practical, goal directed and determined effort to get the required changes effected into the MCI regulations.
It is said "better late than never" so, let us leave the past being and embark upon a strategy to urgently and effectively tackle this issue hence forth. This should be something like a "struggle to the finish". As an initial stimulus, I suggest the following plan of action for consideration by our fellow professionals.
(1) Strengthening the Undergraduate Medical Education should be accepted by the professional body as the current priority goal till it is achieved.
(2) For this purpose, the IPS must prepare a strong logical case to effectively influence the MCI in its next review, or even earlier. (3) The 'Logical Case' must consist of three parts, (a) The first part should consist of summarized examples of the structure of undergraduate psychiatric education in Westem Universities.(b) The second part should consist of a well organised and argued compilation of published evidences to prove the role of psychiatry in every discipline of medical profession, (c) The third part should consist of a practicable structure of training in psychiatry for the medical undergraduates. The structure should include essential syllabus, number of lectures and clinical teachings, and the number and type of questions for the final year examination. (4) The work relating to the first part should be handled by the Indian Psychiatric Society (central body). The work relating to the second part should be distributed to the IPS bodies of the states. For example, each state can undertake to collect evidences in respect of 2 or 3 disciplines (viz: skin, ophthalmology, etc.), and write up Status-Papers. The different components of the work relating to the third part can be allocated to different IPS-zones. (5) The central-IPS should then compile, edit and organize the 'logical case'. This should then be presented to the MCI. The presentation should be preceded by and followed up with adequate and effective lobbying and follow up action till the objective is achieved. This particular stage of action would probably need an elaborately designed plan of action. (6) The status papers (concerning the evidences for the role of psychiatry in each and every LETTERS TO EDITOR discipline of medical profession) by the IPSs of the states, when compiled and edited would form an excellent reference work, and can be published. Such a reference work will also become a basis in future to argue that the postgraduate students of every discipline need 2 to 3 months' posting in psychiatry.
I hope that the profession will rise to the occasion and achieve the desirable end result.
C. SHAMASUNDAR, 250, 43 Cross, 9 Main, 5 Block, Jayanagar, Bangalore 560 041.
HIGH DOSE FLUOXETINE IN OBSESSIVE COMPULSIVE DISORDER

Sir,
Fluoxetine has proven efficacy in treatment of obsessive compulsive disorder (OCD). Double blind, randomized trials of fluoxetine using 20, 40 or 60 mg doses showed a dose response relationship with greater efficacy at 60 mg/day dose (Montgomery et al., 1993; Tollefson et al., 1994) . The maximum recommended dose of fluoxetine in OCD is 80 mg/ day. In literature search I did not come across any report of use of more than 80 mg/day of fluoxetine. I hereby report two cases of OCD who showed good response to more than 80 mg/day of fluoxetine with minimal adverse effects.
Case I: A 40 year old, married male, diagnosed as a case of OCD (ICD-10). The chief symptoms were recurrent intrusive faces of persons known to him, repeated touching of objects in the room an performing rituals while walking on the'road. These symptoms were present for 6 years. Because of severity of symptoms he was unable to carry out his work at home and office. He was given fluoxetine which was increased up to 80 mg/day in four months. The improvement was 75% on this dose. The dose was further increased gradually in two months upto 100 mg/day. There was complete remission of symptoms. The adverse effects were mild anorexia, tremors in hand and occasional headache which decreased further with time.
Case II : A 35 year old married male, shopkeeper by occupation presented with symptoms of repeated checking of money while receiving and returning it back to the customer. Symptoms were affecting his work and was unable to run his shop properly. He was diagnosed as a case of OCD (ICD-10). He was given fluoxet ine to start with 20 mg/day and gradually increased upto 90 mg/day in 6 months. On this dose he showed almost complete remission of symptoms. He continued to have mild anorexia, no other side effect was reported by him.
Both of them are maintained on these doses ior last six months. In view of the above two cases, a conclusion may be drawn that persons suffering from OCD fluoxetine may be given at higher than 80 mg/day, as the improvement is dose related, and side effect are minimal, rather than switching to augmentation or other drugs once the maximum recommended dose of fluoxetine is reached.
